H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies Meeting Abstract


Authors: Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; Klimek, V. M.; Kunii, K.; Lee, L.; Lee, S. C. W.; Liu, X.; Meeske, C.; Mizui, Y.; Padron, E.; Park, E.; Pazolli, E.; Prajapati, S.; Taylor, J.; Wang, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P. G.
Abstract Title: H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-01
Language: English
ACCESSION: WOS:000394446805007
PROVIDER: wos
Notes: Meeting Abstract: 966 -- Source: Wos